HC Wainwright Reiterates Buy Rating for Actinium Pharmaceuticals (NYSE:ATNM)
Actinium Pharmaceuticals (NYSE:ATNM – Get Free Report)‘s stock had its “buy” rating reiterated by investment analysts at HC Wainwright in a research note issued on Tuesday,Benzinga reports. They presently have a $4.00 target price on the stock. HC Wainwright’s price objective would suggest a potential upside of 113.90% from the company’s current price. Actinium Pharmaceuticals […]
Actinium Pharmaceuticals (NYSE:ATNM – Get Free Report)‘s stock had its “buy” rating reiterated by investment analysts at HC Wainwright in a research note issued on Tuesday,Benzinga reports. They presently have a $4.00 target price on the stock. HC Wainwright’s price objective would suggest a potential upside of 113.90% from the company’s current price. Actinium Pharmaceuticals […]
